Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
暂无分享,去创建一个
W. Fridman | C. Griscelli | P. Reinert | J. Teillaud | N. Philippe | M. Debré | M. Bonnet | E. Carosella | E. Vilmer | C. Kaplan | M Debré | C Griscelli | M-C Bonnet | E Carosella | N Philippe | P Reinert | E Vilmer | C Kaplan | W. H Fridman | J-L Teillaud | J. Teillaud
[1] W. Fridman,et al. Isotype regulation of antibody production: T-cell hybrids can be selectively induced to produce IgG1 and IgG2 subclass-specific suppressive immunoglobulin-binding factors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[2] Strong Le,et al. Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. , 1946 .
[3] C. Jacquillat,et al. Soluble circulating Fc gamma receptors in human serum. A new ELISA assay for specific and quantitative detection. , 1987, Journal of immunological methods.
[4] W. Fridman,et al. Recombinant soluble receptors for the Fcγ portion inhibit antibody production in vitro , 1989 .
[5] J. Oncley,et al. The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta1-lipoprotein into subfractions of human plasma. , 1949, Journal of the American Chemical Society.
[6] J. Bussel,et al. Intravenous Treatment with Gammaglobulin in Adults with Immune Thrombocytopenic Purpura: Review of the Literature 1 , 1987, Vox sanguinis.
[7] S. Burdach,et al. Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: comparative efficacy of 7S and 5S preparations. , 1986, The Journal of pediatrics.
[8] W. Fridman. Structures and functions of low affinity Fc receptors , 1989 .
[9] J. Fehr,et al. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. , 1982, The New England journal of medicine.
[10] J. Muller,et al. Evaluation des IgG fixées sur les plaquettes à l'aide d'un test utilisant une antiglobuline radio-active , 1983 .
[11] W. Fridman,et al. Production of an immunoglobulin-binding factor (IBF) by antigen-stimulated lymph node lymphocytes. , 1974, Journal of immunology.
[12] W. Fridman,et al. Fc receptors, immunoglobulin-binding factors and B chronic lymphocytic leukemia. , 1988, Nouvelle revue francaise d'hematologie.
[13] W. Fridman,et al. Involvement of FcR+ T cells and of IgG-BF in the control of myeloma cells. , 1990, Molecular immunology.
[14] S. Wright,et al. Human neutrophil Fc gamma receptor distribution and structure. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Salama,et al. EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA Competitive Inhibition of Reticuloendothelial System Function by Sequestration of Autologous Red Blood Cells? , 1983, The Lancet.
[16] A. Hirt,et al. HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD , 1981, The Lancet.
[17] C. Rabourdin-Combe,et al. Bases for an isotypic network. , 1986, Molecular immunology.
[18] T. Huizinga,et al. The Pi-linked receptor FcRIII is released on stimulation of neutrophils , 1988, Nature.
[19] W. Fridman,et al. Detection and quantification of secreted soluble FcγRIIA in human sera by an enzyme-linked immunosorbent assay , 1993 .
[20] R. Kimberly,et al. Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody , 1986 .
[21] C. Anderson. Structural and functional polymorphism of human Fc receptors for IgG. , 1989, Chemical immunology.
[22] R. Testi,et al. Membrane anchoring and spontaneous release of CD16 (FcR III) by natural killer cells and granulocytes , 1989, European journal of immunology.
[23] J. Bernard,et al. Treatment of adult autoimmune thrombocytopenic purpura with high-dose intravenous plasmin-cleaved gammaglobulins. , 2009, Scandinavian journal of haematology.
[24] J. Bussel. Modulation of Fc receptor clearance and antiplatelet antibodies as a consequence of intravenous immune globulin infusion in patients with immune thrombocytopenic purpura. , 1989, The Journal of allergy and clinical immunology.
[25] S. Kaveri,et al. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases , 1991, Clinical and experimental immunology.
[26] F. Skvaril,et al. Clinical Tolerance and Catabolism of Plasmin‐Treated γ‐Globulin for Intravenous Application , 1975 .
[27] M. Dechavanne,et al. Intravenous plasmin-treated gammaglobulin therapy in idiopathic thrombocytopenic purpura. Results in 40 patients. , 1985, Nouvelle revue francaise d'hematologie.